The clinical significance of drug-placebo differences.
作者信息
Kirsch I
机构信息
Program in Placebo Studies,Harvard Medical School,Boston,USA.
出版信息
Epidemiol Psychiatr Sci. 2018 Jun;27(3):240-241. doi: 10.1017/S2045796017000725. Epub 2017 Nov 23.
Abstract
摘要
相似文献
1
The clinical significance of drug-placebo differences.药物与安慰剂差异的临床意义。
Epidemiol Psychiatr Sci. 2018 Jun;27(3):240-241. doi: 10.1017/S2045796017000725. Epub 2017 Nov 23.
2
Psychoactive drugs. Uses, misuses, and abuses.精神活性药物。用途、误用及滥用。
Prim Care. 1975 Mar;2(1):135-45.
3
Pills or placebos?
Science. 1999 May 7;284(5416):915.
4
Psychotropic drug use and polypharmacy in a general hospital.综合医院中精神药物的使用与联合用药
Gen Hosp Psychiatry. 1981 Mar;3(1):1-9. doi: 10.1016/0163-8343(81)90016-5.
5
[Drug therapy of depressive states].
Rev Med Suisse Romande. 1978 Sep;98(9):507-15.
6
Treatment of refractory depression.
Depress Anxiety. 1997;5(4):165-74.
7
Trimonam and mental retardation.
Curr Ther Res Clin Exp. 1977 Jan;21(1):70-2.
8
[Use of psychotropic agents in somatic medicine].
Klin Med (Mosk). 1976 Aug;54(8):16-20.
9
[Psychotropic drugs. Sense and nonsense in the prescription of sedating, psycholeptic and hypnotic drugs].[精神药物。镇静、抗精神病和催眠药物处方中的合理与不合理之处]
ZFA (Stuttgart). 1980 Jan 20;56(2):77-83.
10
Psychotropic prescription rate rises, despite failure to diagnose.尽管未能确诊，但精神类药物处方率仍在上升。
J Psychosoc Nurs Ment Health Serv. 1998 May;36(5):12-3.
引用本文的文献
1
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study.在患有重度抑郁症的成年人中，与抗抑郁药联合使用唑拉酮的疗效和安全性：来自 3 期 CORAL 研究的结果。
Neuropsychopharmacology. 2024 Jan;49(2):467-475. doi: 10.1038/s41386-023-01751-9. Epub 2023 Oct 24.
2
Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.安慰剂给药对免疫机制的影响及其与中枢内源性阿片神经递质传递的关系。
Mol Psychiatry. 2022 Feb;27(2):831-839. doi: 10.1038/s41380-021-01365-x. Epub 2021 Oct 29.
本文引用的文献
1
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.选择性5-羟色胺再摄取抑制剂与安慰剂治疗重度抑郁症患者的比较：一项Meta分析及序贯试验分析的系统评价
BMC Psychiatry. 2017 Feb 8;17(1):58. doi: 10.1186/s12888-016-1173-2.
2
How effective are common medications: a perspective based on meta-analyses of major drugs.常用药物的效果如何：基于主要药物荟萃分析的视角
BMC Med. 2015 Oct 2;13:253. doi: 10.1186/s12916-015-0494-1.
3
Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences.基于经验得出的标准对抗抑郁药与安慰剂差异的临床意义提出了质疑。
Contemp Clin Trials. 2015 Jul;43:60-2. doi: 10.1016/j.cct.2015.05.005. Epub 2015 May 12.
4
What does the HAMD mean?汉密尔顿抑郁量表（HAMD）是什么？
J Affect Disord. 2013 Jun;148(2-3):243-8. doi: 10.1016/j.jad.2012.12.001. Epub 2013 Jan 26.
5
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses.从精神病学和一般医学药物疗效的角度来看：荟萃分析综述。
Br J Psychiatry. 2012 Feb;200(2):97-106. doi: 10.1192/bjp.bp.111.096594.
6
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.慢性疼痛临床试验的核心结局指标：IMMPACT 建议
Pain. 2005 Jan;113(1-2):9-19. doi: 10.1016/j.pain.2004.09.012.
7
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.采用11点数字疼痛评分量表测量的慢性疼痛强度变化的临床重要性。
Pain. 2001 Nov;94(2):149-158. doi: 10.1016/S0304-3959(01)00349-9.
Zotero 插件